Oscar Health, Inc. $OSCR Position Increased by Allworth Financial LP

Allworth Financial LP lifted its position in Oscar Health, Inc. (NYSE:OSCR) by 2,558.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 12,866 shares of the company’s stock after acquiring an additional 12,382 shares during the period. Allworth Financial LP’s holdings in Oscar Health were worth $276,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in OSCR. Hsbc Holdings PLC boosted its stake in Oscar Health by 2.7% in the 1st quarter. Hsbc Holdings PLC now owns 24,113 shares of the company’s stock worth $313,000 after purchasing an additional 632 shares during the period. Tempus Wealth Planning LLC grew its holdings in shares of Oscar Health by 6.7% during the first quarter. Tempus Wealth Planning LLC now owns 14,392 shares of the company’s stock valued at $189,000 after buying an additional 906 shares in the last quarter. Focus Partners Wealth raised its position in Oscar Health by 1.8% during the first quarter. Focus Partners Wealth now owns 55,158 shares of the company’s stock valued at $723,000 after buying an additional 949 shares during the period. LRI Investments LLC raised its position in Oscar Health by 377.9% during the second quarter. LRI Investments LLC now owns 1,233 shares of the company’s stock valued at $26,000 after buying an additional 975 shares during the period. Finally, Xponance Inc. boosted its position in Oscar Health by 7.1% during the 1st quarter. Xponance Inc. now owns 15,423 shares of the company’s stock worth $202,000 after acquiring an additional 1,029 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Price Performance

NYSE OSCR opened at $14.25 on Tuesday. Oscar Health, Inc. has a fifty-two week low of $11.20 and a fifty-two week high of $23.80. The stock’s 50-day moving average is $18.72 and its two-hundred day moving average is $16.92. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.92 and a quick ratio of 0.92. The firm has a market cap of $3.77 billion, a P/E ratio of -12.73 and a beta of 1.88.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, November 6th. The company reported ($0.53) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.55) by $0.02. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.The company had revenue of $2.93 billion during the quarter, compared to the consensus estimate of $3.09 billion. During the same quarter in the prior year, the company posted ($0.22) EPS. The firm’s revenue was up 23.2% on a year-over-year basis. Oscar Health has set its FY 2025 guidance at EPS. On average, analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on OSCR. Robert W. Baird reiterated a “neutral” rating and issued a $14.00 target price (down previously from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Piper Sandler dropped their price objective on shares of Oscar Health from $14.00 to $13.00 and set a “neutral” rating on the stock in a research note on Thursday, August 14th. The Goldman Sachs Group began coverage on shares of Oscar Health in a research report on Tuesday, October 14th. They issued a “neutral” rating and a $17.00 target price for the company. Wall Street Zen cut shares of Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, August 9th. Finally, Barclays increased their price objective on Oscar Health from $11.00 to $13.00 and gave the stock an “underweight” rating in a report on Monday, November 10th. Six research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Reduce” and a consensus target price of $13.14.

Insider Transactions at Oscar Health

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of the stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total transaction of $7,279,850.00. Following the transaction, the insider owned 501,148 shares in the company, valued at $9,236,157.64. This trade represents a 44.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. 25.11% of the stock is owned by insiders.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.